{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T00:20:16Z","timestamp":1774138816361,"version":"3.50.1"},"reference-count":83,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T00:00:00Z","timestamp":1714348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical Faculty of the Heinrich Heine University D\u00fcsseldorf"}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["IJMS"],"abstract":"<jats:p>Non-muscle invasive bladder cancer is a common tumour in men and women. In case of resistance to the standard therapeutic agents, gemcitabine can be used as off-label instillation therapy into the bladder. To reduce potential side effects, continuous efforts are made to optimise the therapeutic potential of drugs, thereby reducing the effective dose and consequently the pharmacological burden of the medication. We recently demonstrated that it is possible to significantly increase the therapeutic efficacy of mitomycin C against a bladder carcinoma cell line by exposure to non-toxic doses of blue light (453 nm). In the present study, we investigated whether the therapeutically supportive effect of blue light can be further enhanced by the additional use of the wavelength-specific photosensitiser riboflavin. We found that the gemcitabine-induced cytotoxicity of bladder cancer cell lines (BFTC-905, SW-1710, RT-112) was significantly enhanced by non-toxic doses of blue light in the presence of riboflavin. Enhanced cytotoxicity correlated with decreased levels of mitochondrial ATP synthesis and increased lipid peroxidation was most likely the result of increased oxidative stress. Due to these properties, blue light in combination with riboflavin could represent an effective therapy option with few side effects and increase the success of local treatment of bladder cancer, whereby the dose of the chemotherapeutic agent used and thus the chemical load could be significantly reduced with similar or improved therapeutic success.<\/jats:p>","DOI":"10.3390\/ijms25094868","type":"journal-article","created":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T03:30:49Z","timestamp":1714534249000},"page":"4868","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Exposure of Bladder Cancer Cells to Blue Light (\u03bb = 453 nm) in the Presence of Riboflavin Synergistically Enhances the Cytotoxic Efficiency of Gemcitabine"],"prefix":"10.3390","volume":"25","author":[{"given":"Sofia","family":"Sturm","sequence":"first","affiliation":[{"name":"Department of Orthopedics and Trauma Surgery, Medical Faculty, University Hospital D\u00fcsseldorf, Heinrich-Heine-University D\u00fcsseldorf, Moorenstr. 5, 40225 D\u00fcsseldorf, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6929-8691","authenticated-orcid":false,"given":"G\u00fcnter","family":"Niegisch","sequence":"additional","affiliation":[{"name":"Department of Urology, Medical Faculty, University Hospital D\u00fcsseldorf, Heinrich-Heine-University D\u00fcsseldorf, 40225 D\u00fcsseldorf, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Windolf","sequence":"additional","affiliation":[{"name":"Department of Orthopedics and Trauma Surgery, Medical Faculty, University Hospital D\u00fcsseldorf, Heinrich-Heine-University D\u00fcsseldorf, Moorenstr. 5, 40225 D\u00fcsseldorf, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph V.","family":"Suschek","sequence":"additional","affiliation":[{"name":"Department of Orthopedics and Trauma Surgery, Medical Faculty, University Hospital D\u00fcsseldorf, Heinrich-Heine-University D\u00fcsseldorf, Moorenstr. 5, 40225 D\u00fcsseldorf, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,4,29]]},"reference":[{"key":"ref_1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1007\/s00345-019-02984-4","article-title":"The global burden of urinary bladder cancer: An update","volume":"38","author":"Richters","year":"2020","journal-title":"World J. Urol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","article-title":"EAU Guidelines on Non\u2013Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016","volume":"71","author":"Babjuk","year":"2017","journal-title":"Eur. Urol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.eururo.2016.06.020","article-title":"Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer","volume":"71","author":"Witjes","year":"2017","journal-title":"Eur. Urol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5152\/tud.2017.60376","article-title":"What is new in non-muscle-invasive bladder cancer in 2016?","volume":"43","author":"Kamat","year":"2017","journal-title":"Turk. J. Urol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.eururo.2009.06.028","article-title":"Recurrence and progression of disease in non-muscle-invasive bladder cancer: From epidemiology to treatment strategy","volume":"56","author":"Burger","year":"2009","journal-title":"Eur. Urol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrc3817","article-title":"Molecular biology of bladder cancer: New insights into pathogenesis and clinical diversity","volume":"15","author":"Knowles","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.euf.2018.09.009","article-title":"Managing Toxicity of Intravesical Therapy","volume":"4","author":"Mathes","year":"2018","journal-title":"Eur. Urol. Focus"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0090-4295(01)00921-9","article-title":"Leukocyturia as a predictor of tolerance and efficacy of intravesical BCG maintenance therapy for superficial bladder cancer","volume":"57","author":"Saint","year":"2001","journal-title":"Urology"},{"key":"ref_10","first-page":"CD011935","article-title":"Intravesical Bacillus Calmette-Guerin versus mitomycin C for Ta and T1 bladder cancer","volume":"1","author":"Schmidt","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.eururo.2013.05.027","article-title":"Maintenance Bacillus Calmette-Gu\u00e9rin Treatment of Non\u2013muscle-invasive Bladder Cancer: A Critical Evaluation of the Evidence","volume":"64","author":"Ehdaie","year":"2013","journal-title":"Eur. Urol."},{"key":"ref_12","first-page":"244","article-title":"Bacille-Calmette-Guerin non-responders: How to manage","volume":"4","author":"Lerner","year":"2015","journal-title":"Transl. Androl. Urol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/cas.12075","article-title":"Bacillus Calmette\u2013Guerin (BCG) immunotherapy for bladder cancer: Current understanding and perspectives on engineered BCG vaccine","volume":"104","author":"Kawai","year":"2013","journal-title":"Cancer Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nrurol.2014.52","article-title":"Optimizing intravesical mitomycin C therapy in non-muscle-invasive bladder cancer","volume":"11","author":"Zargar","year":"2014","journal-title":"Nat. Rev. Urol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1464-410x.2001.02027.x","article-title":"Cellular resistance to mitomycin C is associated with overexpression of MDR-1 in a urothelial cancer cell line (MGH-U1)","volume":"87","author":"Hayes","year":"2001","journal-title":"BJU Int."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1200\/JCO.2008.20.8199","article-title":"Randomized Phase III Trial on Gemcitabine Versus Mytomicin in Recurrent Superficial Bladder Cancer: Evaluation of Efficacy and Tolerance","volume":"28","author":"Addeo","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/cncr.24914","article-title":"Gemcitabine versus bacille Calmette-Guerin after initial bacille Calmette-Guerin failure in non-muscle-invasive bladder cancer: A multicenter prospective randomized trial","volume":"116","author":"Damiano","year":"2010","journal-title":"Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/ajhp\/54.2.162","article-title":"Gemcitabine: A cytidine analogue active against solid tumors","volume":"54","author":"Hui","year":"1997","journal-title":"Am. J. Health Syst. Pharm."},{"key":"ref_19","unstructured":"(2024, March 12). Guideline Program Oncology (German Cancer Society, German Cancer Aid, AWMF): S3 Guideline for the Early Detection, Diagnosis, Treatment, and Follow-Up of Bladder Cancer, Long Version 2.0, 2020, AWMF Registration Number 032\/038OL. Publisher: Guideline Program Oncology of the Association of the Scientific Medical Societies in Germany (AWMF), German Cancer Society (DKG), and German Cancer Aid Foundation (DKH). Available online: https:\/\/www.leitlinienprogramm-onkologie.de\/leitlinien\/harnblasenkarzinom\/."},{"key":"ref_20","first-page":"195.e7","article-title":"Midterm follow-up (3 years) confirms and extends short-term results of intravesical gemcitabine as bladder-preserving treatment for non\u2013muscle-invasive bladder cancer after BCG failure","volume":"39","author":"Hurle","year":"2020","journal-title":"Urol. Oncol. Semin. Orig. Investig."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1042\/bst0280283","article-title":"The Chemical and Biological Versatility of Riboflavin","volume":"28","author":"Massey","year":"2000","journal-title":"Biochem. Soc. Trans."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0923-1811(99)00061-4","article-title":"A preliminary report of the treatment of blue nevus with dermal injection of riboflavin and exposure to near-ultraviolet\/visible radiation (ribophototherapy)","volume":"23","author":"Sato","year":"2000","journal-title":"J. Dermatol. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jphotobiol.2015.10.030","article-title":"Riboflavin acetate induces apoptosis in squamous carcinoma cells after photodynamic therapy","volume":"153","author":"Juarez","year":"2015","journal-title":"J. Photochem. Photobiol. B"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1002\/jcp.25805","article-title":"Inhibitory effect of blue light emitting diode on migration and invasion of cancer cells","volume":"232","author":"Oh","year":"2017","journal-title":"J. Cell Physiol."},{"key":"ref_25","first-page":"6291","article-title":"Blue light-induced apoptosis of human promyelocytic leukemia cells via the mitochondrial-mediated signaling pathway","volume":"15","author":"Zhuang","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jphotobiol.2014.12.006","article-title":"Effect of blue light emitting diodes on melanoma cells: Involvement of apoptotic signaling","volume":"142","author":"Oh","year":"2015","journal-title":"J. Photochem. Photobiol. B Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1349-7006.2002.tb01290.x","article-title":"Blue light inhibits the growth of B16 melanoma cells","volume":"93","author":"Ohara","year":"2002","journal-title":"Jpn. J. Cancer Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1349-7006.2003.tb01420.x","article-title":"Blue light inhibits the growth of skin tumors in the v-Ha-ras transgenic mouse","volume":"94","author":"Ohara","year":"2003","journal-title":"Cancer Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1200\/jco.2015.33.3_suppl.271","article-title":"Effect of light irradiation by light emitting diode on colon cancer cells and cancer stem cells","volume":"33","author":"Nishi","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_30","first-page":"CD007917","article-title":"Light therapies for acne","volume":"9","author":"Barbaric","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.fsc.2019.09.012","article-title":"Photodynamic Therapy for Photodamage, Actinic Keratosis, and Acne in the Cosmetic Practice","volume":"28","author":"Moy","year":"2020","journal-title":"Facial Plast. Surg. Clin. N. Am."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Becker, D., Langer, E., Seemann, M., Seemann, G., Fell, I., Saloga, J., Grabbe, S., and von Stebut, E. (2011). Clinical efficacy of blue light full body irradiation as treatment option for severe atopic dermatitis. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0020566"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10103-017-2360-1","article-title":"A clinical review of phototherapy for psoriasis","volume":"33","author":"Zhang","year":"2018","journal-title":"Lasers Med. Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/cts.12401","article-title":"A Pilot Metabolic Profiling Study of Patients with Neonatal Jaundice and Response to Phototherapy","volume":"9","author":"Cai","year":"2016","journal-title":"Clin. Transl. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Hegmann, L., Sturm, S., Niegisch, G., Windolf, J., and Suschek, C.V. (2022). Enhancement of human bladder carcinoma cell chemosensitivity to Mitomycin C through quasi-monochromatic blue light (lambda = 453 +\/- 10 nm). J. Photochem. Photobiol. B, 236.","DOI":"10.1016\/j.jphotobiol.2022.112582"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S1011-1344(01)00209-3","article-title":"Effect of visible light on selected enzymes, vitamins and amino acids","volume":"63","author":"Edwards","year":"2001","journal-title":"J. Photochem. Photobiol. B Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1007\/s10495-006-9549-2","article-title":"A promising action of riboflavin as a mediator of leukaemia cell death","volume":"11","author":"Kodach","year":"2006","journal-title":"Apoptosis"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jphotobiol.2011.01.012","article-title":"Different cell death mechanisms are induced by a hydrophobic flavin in human tumor cells after visible light irradiation","volume":"103","author":"Pacheco","year":"2011","journal-title":"J. Photochem. Photobiol. B"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.canlet.2007.08.024","article-title":"A possible anti-proliferative and anti-metastatic effect of irradiated riboflavin in solid tumours","volume":"258","author":"Queiroz","year":"2007","journal-title":"Cancer Lett."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Machado, D., Shishido, S.M., Queiroz, K.C.S., Oliveira, D.N., Faria, A.L.C., Catharino, R.R., Spek, C.A., and Ferreira, C.V. (2013). Irradiated Riboflavin Diminishes the Aggressiveness of Melanoma In Vitro and In Vivo. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0054269"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s13277-014-2675-5","article-title":"Antitumor activity of irradiated riboflavin on human renal carcinoma cell line 786-O","volume":"36","author":"Neto","year":"2015","journal-title":"Tumor Biol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"9679","DOI":"10.1038\/s41598-019-46115-w","article-title":"Photodynamic therapy of melanoma by blue-light photoactivation of flavin mononucleotide","volume":"9","author":"Akasov","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.eururo.2020.12.033","article-title":"European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004\/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel","volume":"79","author":"Sylvester","year":"2021","journal-title":"Eur. Urol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur. Urol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.addr.2018.09.004","article-title":"The effect of low- and high-penetration light on localized cancer therapy","volume":"138","author":"Costa","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Dunkel, P., and Ila\u0161, J. (2021). Targeted Cancer Therapy Using Compounds Activated by Light. Cancers, 13.","DOI":"10.3390\/cancers13133237"},{"key":"ref_47","first-page":"734","article-title":"Light-Activated Phytochemicals in Photodynamic Therapy for Cancer: A Mini Review","volume":"40","author":"George","year":"2022","journal-title":"Photobiomodul. Photomed. Laser Surg."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"905606","DOI":"10.3389\/fmed.2022.905606","article-title":"The microbicidal potential of visible blue light in clinical medicine and public health","volume":"9","author":"Haridas","year":"2022","journal-title":"Front. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5978\/islsm.20.17","article-title":"A possible mechanism for the bactericidal effect of visible light","volume":"20","author":"Lubart","year":"2011","journal-title":"Laser Ther."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10103-023-03951-7","article-title":"Photobiomodulation effects of blue light on osteogenesis are induced by reactive oxygen species","volume":"39","author":"Albaqami","year":"2023","journal-title":"Lasers Med. Sci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"5564","DOI":"10.2174\/0929867324666170727112206","article-title":"Visible Blue Light Therapy: Molecular Mechanisms and Therapeutic Opportunities","volume":"25","author":"Garza","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1200\/JCO.2023.41.6_suppl.528","article-title":"A phase II clinical study of intravesical photo dynamic therapy in patients with BCG-unresponsive NMIBC (interim analysis)","volume":"41","author":"Kulkarni","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1159\/000448000","article-title":"Prospective, Randomized Study on the Efficacy and Safety of Local UV-Free Blue Light Treatment of Eczema","volume":"232","author":"Keemss","year":"2016","journal-title":"Dermatology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1464-410X.2011.10880.x","article-title":"Intravesical gemcitabine therapy for non-muscle invasive bladder cancer (NMIBC): A systematic review","volume":"109","author":"Shelley","year":"2012","journal-title":"BJU Int."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3892\/or.2013.2882","article-title":"Therapeutic potential of sepantronium bromide YM155 in gemcitabine-resistant human urothelial carcinoma cells","volume":"31","author":"Huang","year":"2014","journal-title":"Oncol. Rep."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1158\/1078-0432.CCR-14-0542","article-title":"Deoxycytidine kinase expression underpins response to gemcitabine in bladder cancer","volume":"20","author":"Kerr","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/j.juro.2011.06.053","article-title":"Induction of caspase mediated apoptosis and down-regulation of nuclear factor-kappaB and Akt signaling are involved in the synergistic antitumor effect of gemcitabine and the histone deacetylase inhibitor trichostatin A in human bladder cancer cells","volume":"186","author":"Jeon","year":"2011","journal-title":"J. Urol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00280-016-3003-0","article-title":"Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: An EORTC-PAMM perspective","volume":"78","author":"Ciccolini","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Krassovka, J.M., Suschek, C.V., Prost, M., Grotheer, V., Schiefer, J.L., Demir, E., Fuchs, P.C., Windolf, J., St\u00fcrmer, E.K., and Opl\u00e4nder, C. (2020). The impact of non-toxic blue light (453 nm) on cellular antioxidative capacity, TGF-beta1 signaling, and myofibrogenesis of human skin fibroblasts. J. Photochem. Photobiol. B, 209.","DOI":"10.1016\/j.jphotobiol.2020.111952"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/jid.2009.194","article-title":"Blue-light irradiation regulates proliferation and differentiation in human skin cells","volume":"130","author":"Liebmann","year":"2010","journal-title":"J. Investig. Dermatol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jphotobiol.2011.02.018","article-title":"Effects of blue light irradiation on human dermal fibroblasts","volume":"103","author":"Hidding","year":"2011","journal-title":"J. Photochem. Photobiol. B"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jphotobiol.2017.06.014","article-title":"Blue light induced reactive oxygen species from flavin mononucleotide and flavin adenine dinucleotide on lethality of HeLa cells","volume":"173","author":"Yang","year":"2017","journal-title":"J. Photochem. Photobiol. B"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"823902","DOI":"10.1155\/2012\/823902","article-title":"Reactive oxygen species and inhibitors of inflammatory enzymes, NADPH oxidase, and iNOS in experimental models of Parkinson\u2019s disease","volume":"2012","author":"Koppula","year":"2012","journal-title":"Mediat. Inflamm."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"129499","DOI":"10.1016\/j.chemosphere.2020.129499","article-title":"A review of dietary phytochemicals and their relation to oxidative stress and human diseases","volume":"271","author":"Guan","year":"2021","journal-title":"Chemosphere"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.tips.2017.04.005","article-title":"Targeting Free Radicals in Oxidative Stress-Related Human Diseases","volume":"38","author":"Poprac","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Arthaut, L.-D., Jourdan, N., Mteyrek, A., Procopio, M., El-Esawi, M., D\u2019harlingue, A., Bouchet, P.-E., Witczak, J., Ritz, T., and Klarsfeld, A. (2017). Blue-light induced accumulation of reactive oxygen species is a consequence of the Drosophila cryptochrome photocycle. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0171836"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"6255","DOI":"10.1073\/pnas.96.11.6255","article-title":"Activation of flavin-containing oxidases underlies light-induced production of H2O2 in mammalian cells","volume":"96","author":"Hockberger","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jphotobiol.2015.01.005","article-title":"Investigations of blue light-induced reactive oxygen species from flavin mononucleotide on inactivation of E. coli","volume":"143","author":"Liang","year":"2015","journal-title":"J. Photochem. Photobiol. B"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"774","DOI":"10.3109\/10715762.2013.829570","article-title":"Blue LED light exposure develops intracellular reactive oxygen species, lipid peroxidation, and subsequent cellular injuries in cultured bovine retinal pigment epithelial cells","volume":"47","author":"Majima","year":"2013","journal-title":"Free Radic. Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jphotobiol.2017.08.018","article-title":"Blue light induced free radicals from riboflavin in degradation of crystal violet by microbial viability evaluation","volume":"174","author":"Liang","year":"2017","journal-title":"J. Photochem. Photobiol. B"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jphotobiol.2017.07.009","article-title":"Effects of blue or violet light on the inactivation of Staphylococcus aureus by riboflavin-5\u2032-phosphate photolysis","volume":"173","author":"Wong","year":"2017","journal-title":"J. Photochem. Photobiol. B"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jphotobiol.2012.12.007","article-title":"Blue light induced free radicals from riboflavin on E. coli DNA damage","volume":"119","author":"Liang","year":"2013","journal-title":"J. Photochem. Photobiol. B"},{"key":"ref_73","first-page":"1291","article-title":"Augmentation of the inhibitory effect of blue light on the growth of B16 melanoma cells by riboflavin","volume":"22","author":"Ohara","year":"2003","journal-title":"Int. J. Oncol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1038\/sj.onc.1207559","article-title":"Regulation of the apoptosis\u2013necrosis switch","volume":"23","author":"Nicotera","year":"2004","journal-title":"Oncogene"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/mc.2940130307","article-title":"Overexpression of MDM-2 mRNA and mutation of the p53 tumor suppressor gene in bladder carcinoma cell lines","volume":"13","author":"Cheng","year":"1995","journal-title":"Mol. Carcinog."},{"key":"ref_76","first-page":"3630","article-title":"Tissue culture model of transitional cell carcinoma: Characterization of twenty-two human urothelial cell lines","volume":"46","author":"Masters","year":"1986","journal-title":"Cancer Res."},{"key":"ref_77","first-page":"3997","article-title":"Morphological, biological, and biochemical characteristics of human bladder transitional cell carcinomas grown in tissue culture and in nude mice","volume":"44","author":"Kyriazis","year":"1984","journal-title":"Cancer Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13046-015-0259-x","article-title":"Phenotype plasticity rather than repopulation from CD90\/CK14+ cancer stem cells leads to cisplatin resistance of urothelial carcinoma cell lines","volume":"34","author":"Skowron","year":"2015","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s00726-017-2437-y","article-title":"beta-Alanine intercede metabolic recovery for amelioration of human cervical and renal tumors","volume":"49","author":"Pandurangan","year":"2017","journal-title":"Amino Acids"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1139\/o70-119","article-title":"Some reactions of sterculic and malvalic acids. A new source of malvalic acid","volume":"48","author":"Roomi","year":"1970","journal-title":"Can. J. Biochem."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"9251303","DOI":"10.1155\/2017\/9251303","article-title":"Arsenite Effects on Mitochondrial Bioenergetics in Human and Mouse Primary Hepatocytes Follow a Nonlinear Dose Response","volume":"2017","author":"Chavan","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1002\/ajmg.a.40526","article-title":"Preliminary observations of mitochondrial dysfunction in Prader\u2013Willi syndrome","volume":"176","author":"Butler","year":"2018","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Mookerjee, S.A., and Brand, M.D. (2015). Measurement and Analysis of Extracellular Acid Production to Determine Glycolytic Rate. J. Vis. Exp., e53464.","DOI":"10.3791\/53464-v"}],"updated-by":[{"DOI":"10.3390\/ijms26104790","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T00:00:00Z","timestamp":1714348800000}}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/9\/4868\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T14:31:37Z","timestamp":1754231497000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/9\/4868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,29]]},"references-count":83,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["ijms25094868"],"URL":"https:\/\/doi.org\/10.3390\/ijms25094868","relation":{"correction":[{"id-type":"doi","id":"10.3390\/ijms26104790","asserted-by":"object"}]},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,29]]}}}